Skip to main content

Table 1 The clinical characteristics and laboratory data of the 99 adults with cryptococcal meningitis

From: The clinical characteristics and therapeutic outcomes of cryptococcal meningitis in elderly patients: a hospital-based study

 

Non-elderly group (n = 61)

Elderly group (n = 38)

p-value

Gender

 Male

48

16

< 0.001

 Female

13

22

 

Mortality at discharge

19

14

0.597

Underlying disease

 AIDS

11

1

0.026

 Diabetes mellitus

8

15

0.003

 Liver cirrhosis

6

3

1.000

 Hematologic disorders

7

5

1.000

 Autoimmune disorders

7

3

0.737

 Malignancy

3

6

0.083

 Chronic obstructive pulmonary disease

0

5

0.007

 Adrenal insufficiency

1

7

0.005

 Organ transplantation

1

0

1.000

 Immunocompromised state

26

17

0.837

Initial presentation

   

 Headache

48

17

0.001

 Altered consciousness

20

29

< 0.001

 Fever

39

21

0.390

 Seizure

9

6

0.889

 Visual disturbance

15

1

0.004

 Hearing impairment

5

1

0.402

Cerebrospinal fluid data

White blood cell count (109/L)

0.17

0.09

0.022

 Glucose (mmol/L)

2.18

2.92

0.153

 Protein (g/L)

1.50

2.54

0.186

 Lactate (mmol/L)

5.25

5.35

0.896

 Positive India ink stain

22

9

0.113

 Cryptococcal Ag titer (≥1:1024)

26

12

0.163

 Positive culture result

51

26

0.004

Serum cryptococcal Ag titer (≥1:1024)

22

12

0.766

Cryptococcemia

21

9

0.258

Extraneural involvement

5

5

0.501

Neuroimaging findings

 Basal meningeal enhancement

22

12

0.584

 Pseudocyst/VR space dilatation

18

14

0.394

 Hydrocephalus

18

15

0.263

 Recent cerebral infarction

3

11

0.001

 Cryptococcoma

5

1

0.404

  1. AIDS acquired immunodeficiency syndrome, Ag antigen, VR Virchow-Robin